The Metabolic Syndrome.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c25805 ) has announced the addition of The Metabolic Syndrome to their offering Metabolic syndrome has become a 'hot topic', relevant to both scientists and clinicians. An increasing number of scientists are interested in the pathogenesis of metabolic syndrome and its relationship with diabetes and coronary heart disease coronary heart disease: see coronary artery disease. coronary heart disease or ischemic heart disease Progressive reduction of blood supply to the heart muscle due to narrowing or blocking of a coronary artery (see atherosclerosis). (CHD CHD coronary heart disease. ChD abbr. Latin Chirurgiae Doctor (Doctor of Surgery) CHD, n.pr See disease, coronary heart. CHD canine hip dysplasia. ). Primary health care professionals have become aware of the increasing problem of obesity, the importance of insulin resistance and its relevance to type 2 diabetes type 2 diabetes n. See diabetes mellitus. and CHD. Secondary care health care professionals working in diabetes and cardiology are realising that the majority of their patients have metabolic syndrome but are not sure how to manage this problem. Gynaecologists have for some time appreciated that patients with cystic ovaries Ovaries The female sex organs that make eggs and female hormones. Mentioned in: Choriocarcinoma ovaries (ō´v and amenorrhea amenorrhea (āmĕn'ərē`a, əmĕn'–), cessation of menstruation. Primary amenorrhea is a delay in or a failure to start menstruation; secondary amenorrhea is an unexpected stop to the menstrual cycle. have polycystic ovarian syndrome Polycystic ovarian syndrome (PCOS) A condition in which the eggs are not released from the ovaries and instead form multiple cysts. Mentioned in: Oophorectomy, Ovarian Cysts and treatment with an insulin sensitising Noun 1. sensitising - rendering an organism sensitive to a serum by a series of injections sensitizing, sensitisation, sensitization immunisation, immunization - the act of making immune (especially by inoculation) Adj. 1. agent such as metformin metformin /met·for·min/ (met-for´min) an antihyperglycemic agent that potentiates the action of insulin, used in the treatment of type 2 diabetes mellitus. met·for·min n. is effective. Hepatologists have realised that many of their patients, referred for investigation of fatty liver, have metabolic syndrome but do not know what to do to treat this problem. Suddenly the metabolic syndrome has become relevant to many different, but now related disciplines, in clinical medicine. This book highlights specific important themes pertinent to the metabolic syndrome and will appeal to a broad readership. Preface. List of Contributors. 1.The Global Burden of the Metabolic Syndrome and its Consequences for Diabetes and Cardiovascular Disease (Sarah H. Wild and Christopher D. Byrne). 2. Ethnicity and the Metabolic Syndrome (Nita G. Forouhi). 3. Developmental Origins of Vascular Dysfunction and Disease (Simon Cunningham and Mark Hanson). 4. Developmental Origins of Insulin Resistance and Type 2 Diabetes (Roselle Roselle (rōzĕl`), borough (1990 pop. 20,314), Union co., NE N.J.; set off from Linden 1890 and inc. 1894. Chiefly residential, the borough has some industry. L. Cripps and Susan E. Ozanne). 5. Recent Progress in the Identification of Genes Predisposing to the Metabolic Syndrome (Timothy M. Frayling, Kirsten J. Ward and Michael N. Weedon). 6. Atherothrombosis and the Metabolic Syndrome (Emma J. Dunn and Peter J. Grant). 7. Oxidative Stress, Insulin Resistance and Cardiovascular Disease (Antonio Ceriello). 8. Inflammation, Cardiovascular Disease and the Metabolic Syndrome (Dan Ziegler). 9. Adipocytokines and the Pathogenesis of the Metabolic Syndrome (Ulf Smith and Xiaolin Yang). 10. Peripheral Arterial Disease (Lorna Watson and Gerry F. Fowkes). 11. Non-alcoholic Steatohepatitis (Mohammed H. Ahmed and Christopher D. Byrne). 12. Polycystic Ovary Syndrome Polycystic Ovary Syndrome Definition Polycystic ovary syndrome (PCOS) is a condition characterized by the accumulation of numerous cysts (fluid-filled sacs) on the ovaries associated with high male hormone levels, chronic anovulation (absent ovulation), (Naveed Sattar and Richard Fleming). 13. Nutrition: its Relevance in Development and Treatment of the Metabolic Syndrome (Jim Mann and Kirsten McAuley). 14. Growth Hormone, Exercise and Energy Expenditure in the Metabolic Syndrome (Cathy M. McHugh and Richard I.G. Holt). 15. Treatments for the Metabolic Syndrome (Markolf Hanefeld and Frank Schaper). Summary Christopher Byrne, a diabetologist and clinician scientist, and Sarah Wild, an epidemiologist and public health physician, have brought together a group of authors, all of whom are leading researchers in their field. The editors and chapter authors have each contributed chapters addressing hot topics relevant to the metabolic syndrome. These state-of-the-art chapters range from aetiology aetiology see etiology. to pathogenesis, complications and treatment, addressing subjects such as the developmental origins of the metabolic syndrome, oxidation, inflammation and exciting new areas such as non-alcoholic steatohepatitis and adipocytokines. This book will appeal to all researchers and clinicians requiring detailed up to date information on the metabolic syndrome to further their own research or to treat and manage the syndrome and its complications. For more information visit http://www.researchandmarkets.com/reports/c25805 |
|
||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion